Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $485 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a $485 price target.
May 22, 2023 | 12:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly and maintains a $485 price target.
The news directly mentions Eli Lilly (NYSE:LLY) and the analyst's reiterated Overweight rating and maintained price target of $485. This positive rating from a reputable analyst is likely to have a positive short-term impact on the stock price, as it signals confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100